The estimated Net Worth of Richard Dana Ono is at least $55.4 Tisíc dollars as of 20 March 2023. Richard Ono owns over 4,000 units of Lipocine Inc stock worth over $55,370 and over the last 11 years he sold LPCN stock worth over $0. In addition, he makes $0 as Director at Lipocine Inc.
Sign up
Richard Ono LPCN stock SEC Form 4 insiders trading
Richard has made over 4 trades of the Lipocine Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 4,000 units of LPCN stock worth $1,360 on 20 March 2023.
The largest trade he's ever made was exercising 5,250 units of Lipocine Inc stock on 16 December 2020 worth over $20,580. On average, Richard trades about 882 units every 179 days since 2014. As of 20 March 2023 he still owns at least 14,125 units of Lipocine Inc stock.
You can see the complete history of Richard Ono stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Richard Ono biography
Dr. Richard Dana Ono is Director of the Lipocine Inc. Dr. Ono brings 30 years of experience managing public and private life science companies. Throughout his career, he has been engaged in strategic planning, product management, technology acquisition, and commercial development for multiple early stage life science companies and has been involved in a number of key advances for the industry. Dr. Ono has founded several biotech companies in the U.S., including IntraImmune Therapies, Inc., a biotechnology company which he sold to Abgenix, Inc. (now Amgen), along with several successful early stage biotech companies in the Boston area. Currently, he is a venture partner at VIMAC Ventures LLC. Dr. Ono received his AB in Earth & Planetary Sciences from The Johns Hopkins University and his AM and PhD in Biology from Harvard University, where he also completed a program in business administration.
How old is Richard Ono?
Richard Ono is 62, he's been the Director of Lipocine Inc since 2014. There are 3 older and 9 younger executives at Lipocine Inc. The oldest executive at Lipocine Inc is Dr. Mahesh V. Patel Ph.D., 64, who is the Co-Founder, Interim Principal Financial Officer, Chairman, Pres & CEO.
What's Richard Ono's mailing address?
Richard's mailing address filed with the SEC is C/O 675 ARAPEEN DR, SUITE 202, SALT LAKE CITY, UT, 84108.
Insiders trading at Lipocine Inc
Over the last 11 years, insiders at Lipocine Inc have traded over $9,045 worth of Lipocine Inc stock and bought 890,945 units worth $696,169 . The most active insiders traders include Mahesh V. Patel, John W. Higuchi a Morgan R Brown. On average, Lipocine Inc executives and independent directors trade stock every 72 days with the average trade being worth of $148,846. The most recent stock trade was executed by Mahesh V. Patel on 25 May 2023, trading 8,706 units of LPCN stock currently worth $43,791.
What does Lipocine Inc do?
lipocine inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. the company develops drugs based on hydroance, a drug delivery technology. it primarily focuses on developing oral versions of several hormones for use in men and women health. the company’s lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. it also offers custom drugs for pharmaceutical/biotechnology companies. lipocine inc. was founded in 1997 and is headquartered in salt lake city, utah.
What does Lipocine Inc's logo look like?
Complete history of Richard Ono stock trades at Lipocine Inc a Inhibitor Therapeutics
Lipocine Inc executives and stock owners
Lipocine Inc executives and other stock owners filed with the SEC include:
-
Mahesh Patel,
Chairman of the Board, President, Chief Executive Officer -
Dr. Mahesh V. Patel Ph.D.,
Co-Founder, Interim Principal Financial Officer, Chairman, Pres & CEO -
Dr. Mahesh V. Patel,
Co-Founder, Chairman, Pres & CEO -
Morgan R. Brown CPA, CPA, M.B.A., MBA,
Corp. Sec. -
Morgan R. Brown CPA, M.B.A., CPA, MBA,
Exec. VP, CFO, Principal Accounting Officer & Corp. Sec. -
Morgan Brown,
Chief Financial Officer, Executive Vice President -
Nachiappan Chidambaram Ph.D.,
VP of Product Devel. -
John Higuchi,
Non-Executive Director -
Richard Ono,
Director -
Jeffrey Fink,
Director -
Stephen Hill,
Lead Independent Director -
Krista Fogarty,
Principal Accounting Officer & Corp. Controller -
Dr. Anthony DelConte M.D., M. D.,
Chief Medical Director -
Logan Morse,
VP of Sales, Marketing & Operations -
Jyrki Mattila,
Chief Business Officer -
Gregory Brooks Bass,
EVP and Chief Commercial Offic -
Srinivasan Venkateshwaran,
CTO and VP RandD -
Gerald T Simmons,
VP Corp Business Development -
Robert K. Merrell,
VP Finance -
Jill M. Jene,
Director -
Spyros Papapetropoulos,
Director -
Krista Fogarty,
Principal Accounting Officer -
George Nomikos,
Chief Medical Officer